跳至主要内容
临床试验/NCT02277782
NCT02277782终止不适用

Intrathecal Hydromorphone for Labor Analgesia

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2015年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
21
试验地点
1
主要终点
Effect on maternal temperature during labor

研究概览

简要总结

The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will:

  1. Prolong the duration and improve the quality of analgesia in labor, and
  2. Decrease the incidence of epidural-associated temperature increase in labor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients are eligible for enrollment if they are healthy, pregnant females between the ages of 18 and 45 years, primiparous, and at term gestation (≥ 37 weeks).

排除标准

  • Patients with a Category II or III fetal heart rate tracing, a fetus with intrauterine growth restriction, prolonged rupture of membranes, recent diagnosis of infection of any cause, or in whom dural puncture is contraindicated will be excluded from the study.

研究组 & 干预措施

No Hydromorphone

Active Comparator

1.7 mg bupivacaine + 17 mcg fentanyl + 0.05 ml of 0.9% normal saline.

干预措施: Hyperbaric bupivacaine (Drug)

No Hydromorphone

Active Comparator

1.7 mg bupivacaine + 17 mcg fentanyl + 0.05 ml of 0.9% normal saline.

干预措施: Fentanyl (Drug)

Hydromorphone

Experimental

1.7 mg bupivacaine + 17 mcg fentanyl + 50 mcg preservative-free hydromorphone (0.05 ml)

干预措施: Hydromorphone (Drug)

Hydromorphone

Experimental

1.7 mg bupivacaine + 17 mcg fentanyl + 50 mcg preservative-free hydromorphone (0.05 ml)

干预措施: Hyperbaric bupivacaine (Drug)

Hydromorphone

Experimental

1.7 mg bupivacaine + 17 mcg fentanyl + 50 mcg preservative-free hydromorphone (0.05 ml)

干预措施: Fentanyl (Drug)

结局指标

主要结局

Effect on maternal temperature during labor

时间窗: 2 years

The primary outcome measure will be the incidence of maternal temperature increase, defined as an increase in maternal temperature by 1 degree celsius over the baseline temperature recorded prior to the onset of epidural analgesia.

次要结局

  • Effect on efficacy of labor analgesia(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dominique Arce

Instructor of Anaesthesia

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验